Private company
Forbion Capital Fund III Cooperatief U.A.
Last updated Oct 21, 2026.
Overview
- HeadquartersP71
Corporate structure
Forbion Capital Fund III Cooperatief U.A. sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Forbion Capital Fund III Cooperatief U.A. P7
- enGene Therapeutics Inc. Stake · Z4
- Replimune Group, Inc. Stake · Woburn, Massachusetts, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.
Stakes it holds
Forbion Capital Fund III Cooperatief U.A. has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).
- Replimune Group, Inc.SCHEDULE 13G/A Feb 14, 2024 to Feb 17, 20262
- enGene Therapeutics Inc.SC 13G/A Nov 13, 2023 to Feb 14, 20243
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3